Marka Lewis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

An analysis of global online conversations among health care professionals on social media in April revealed tremendous enthusiasm about FDA approval of a treatment for adults with advanced HER2-positive solid tumors. The FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki (Enhertu; AstraZeneca, Daiichi Sankyo) — a HER2-directed antibody-drug conjugate previously approved

In case you missed any, below is a recap of every episode of OncLive On Air that aired in March 2024.

Conflicting guidance about when to start CRC screening puts ambiguities about the optimal screening age front and center and has raised concerns among some doctors.

Multiple factors impact colorectal cancer screening rates, but psychological barriers may lie at the core of many people's hesitancy. Personalized outreach strategies could help boost participation.

Issue 256: Two adult-use stores opened; N.J.-N.Y.-MA regulators exchange ideas; 2022 tax revenue report; our awards, and more